Literature DB >> 6137306

Hepatic enzyme induction patterns and phenothiazine side effects.

J H Wright, S B Whitaker, C B Welch, D N Teller.   

Abstract

D-Glucaric acid excretion was followed in psychotic patients treated with phenothiazines for 12 days and in a control group of subjects who had no psychiatric disease. About half the psychiatric patients had a treatment-related rise in D-glucaric acid excretion compatible with enzyme induction. These patients had fewer and less severe neurologic side effects than those who did not have a significant rise in urinary D-glucaric acid levels. It is concluded that individual differences in metabolism of phenothiazines may in part account for the variability in clinical response to these drugs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6137306     DOI: 10.1038/clpt.1983.210

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  3 in total

Review 1.  Use of phenothiazines as sedatives in children: what are the risks?

Authors:  K S Dyer; A D Woolf
Journal:  Drug Saf       Date:  1999-08       Impact factor: 5.606

2.  D-glucaric acid excretion in critical care patients--comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy.

Authors:  G Heinemeyer; I Roots; P Lestau; H R Klaiber; R Dennhardt
Journal:  Br J Clin Pharmacol       Date:  1986-01       Impact factor: 4.335

3.  Metabolomic Profiling of Post-Mortem Brain Reveals Changes in Amino Acid and Glucose Metabolism in Mental Illness Compared with Controls.

Authors:  Rong Zhang; Tong Zhang; Ali Muhsen Ali; Mohammed Al Washih; Benjamin Pickard; David G Watson
Journal:  Comput Struct Biotechnol J       Date:  2016-02-26       Impact factor: 7.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.